Functional imaging of the dopamine system: in vivo evaluation of dopamine deficiency and restoration.
Dopamine deficiency causes a severe impairment in motor function in patients with Parkinson's disease (PD) and in experimental animal models. Recent developments in neuroimaging techniques provide a means to assess in vivo the state of the dopamine system. From a functional perspective, four levels need to be operative and integrated in the system: the dopamine cell (pre-synaptic), the striatal dopamine receptors (post-synaptic), adequate release of dopamine (intra-synaptic), and the cortico-subcortical motor projections. Neuroimaging functional methods can be used to estimate, at these four levels, dopamine cell degeneration, adaptive responses to injury and, importantly, the effect of therapeutic interventions. In this respect, data from functional imaging studies at clinical and pre-clinical stages, support the idea that cell replacement therapy might achieve a more physiological restoration of the dopamine motor system than other therapies (such as ablative surgery, administration of precursor, deep brain stimulation) that currently are equally or more effective in relieving motor symptoms.
Sánchez-Pernaute
R
R
Udall Parkinson's Disease Research Center of Excellence, Neuroregeneration Laboratory, McLean Hospital/Harvard Medical School, Belmont, MA 02478, USA.
Brownell
A L
AL
Isacson
O
O
D000818:Animals; D004298:Dopamine / Q000172:deficiency* / Q000502:physiology*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D017551:Microdialysis; D009046:Motor Neurons / Q000473:pathology; D009415:Nerve Net / Q000378:metabolism / Q000473:pathology; D009420:Nervous System / Q000473:pathology*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000473:pathology*; D017729:Presynaptic Terminals / Q000473:pathology; D011954:Receptors, Dopamine / Q000378:metabolism / Q000502:physiology
D011954:Receptors, Dopamine; D004298:Dopamine